C12Y 114/11027
[histone h3]-lysine-36 demethylase
Official title: [Histone H3]-lysine-36 demethylase (1.14.11.27)
C12Y114/11027 ([histone h3]-lysine-36 demethylase) appears on 11 US grants and 25 published applications in this corpus.
Search patents in C12Y- Granted patents
- 11
- Published applications
- 25
- Assignees
- 15
- Inventors
- 45
- Latest grant
- 26 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 0 | 0 |
| 2014 | 0 | 1 |
| 2015 | 1 | 2 |
| 2016 | 1 | 1 |
| 2017 | 1 | 1 |
| 2018 | 2 | 4 |
| 2019 | 0 | 0 |
| 2020 | 1 | 4 |
| 2021 | 1 | 4 |
| 2022 | 1 | 4 |
| 2023 | 2 | 0 |
| 2024 | 0 | 3 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Compositions and methods for generating physiological X chromosome inactivation26 May 2026US 12,637,697 B2Children's Medical Center Corporation
- Reprogramming cell aging12 Sep 2023US 11,754,551 B2Memorial Sloan Kettering Cancer Center
- Histone demethylase inhibitors22 Aug 2023US 11,731,954 B2
- Method for identifying compound for inhibiting an activity of a histone lysine demethylase22 Mar 2022US 11,279,966 B2National Tsing Hua University
- Histone demethylase inhibitors11 May 2021US 11,001,568 B2Celgene Quanticel Research, Inc.
- Inducible single aav system and uses thereof28 Nov 2024US 2024/0390518 A9University of Massachusetts
- Inducible single aav system and uses thereof18 Apr 2024US 2024/0123086 A1University of Massachusetts
- Targeted gene regulation of human immune cells with crispr-cas systems25 Jan 2024US 2024/0026352 A1
- Cell permeable proteins for genome engineering24 Nov 2022US 2022/0372089 A1Altius Institute for Biomedical Sciences
- Methods and compositions involving tert activating therapies6 Oct 2022US 2022/0313782 A1Board of Regents, The University of Texas System
Most cited
By later US patents
- Histone demethylase inhibitors3US 10,059,687 B2Celgene Quanticel Research, Inc. · 2018
- Histone demethylase inhibitors1US 10,597,379 B2Celgene Quanticel Research, Inc. · 2020
- Histone demethylase inhibitors1US 11,001,568 B2Celgene Quanticel Research, Inc. · 2021
- Method for identifying compound for inhibiting an activity of a histone lysine demethylase1US 9,890,434 B2National Tsing Hua University · 2018